000 | 02065 a2200565 4500 | ||
---|---|---|---|
005 | 20250512055645.0 | ||
264 | 0 | _c19860703 | |
008 | 198607s 0 0 eng d | ||
022 | _a0002-9343 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDe Jongh, C A | |
245 | 0 | 0 |
_aA double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. _h[electronic resource] |
260 |
_bThe American journal of medicine _cMay 1986 |
||
300 |
_a101-11 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAgranulocytosis _xcomplications |
650 | 0 | 4 |
_aAmikacin _xadministration & dosage |
650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
650 | 0 | 4 |
_aBlood Bactericidal Activity _xdrug effects |
650 | 0 | 4 |
_aBlood Coagulation Disorders _xchemically induced |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDrug Hypersensitivity _xetiology |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aFever _xdrug therapy |
650 | 0 | 4 |
_aHearing Disorders _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfections _xetiology |
650 | 0 | 4 |
_aKanamycin _xanalogs & derivatives |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMoxalactam _xadministration & dosage |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 |
_aPiperacillin _xadministration & dosage |
650 | 0 | 4 | _aRandom Allocation |
700 | 1 | _aJoshi, J H | |
700 | 1 | _aThompson, B W | |
700 | 1 | _aNewman, K A | |
700 | 1 | _aFinley, R S | |
700 | 1 | _aMoody, M R | |
700 | 1 | _aSalvatore, P C | |
700 | 1 | _aTenney, J H | |
700 | 1 | _aDrusano, G L | |
700 | 1 | _aSchimpff, S C | |
773 | 0 |
_tThe American journal of medicine _gvol. 80 _gno. 5C _gp. 101-11 |
|
999 |
_c3526991 _d3526991 |